Immunome, Inc. (IMNM)

Healthcare · Biotechnology · NASDAQ

Immunome, Inc. (IMNM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.83B and a free-cash-flow yield of -9.5%. Over the most recent reported fiscal year, revenue declined 23.2%.

Market cap	$2.83B
Trailing P/E	—
FCF yield	-9.5%
Revenue growth (YoY)	-23.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IMNM data on Nama Insights →